您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (6): 91-95.doi: 10.6040/j.issn.1671-7554.0.2024.0011

• 临床医学 • 上一篇    

经颈部静脉旁路术治疗锁骨下静脉闭塞所致透析内瘘失功

何兰兰1,杨轲2,任万军3,王小平3   

  • 发布日期:2024-07-15
  • 通讯作者: 王小平. E-mail:wangxiaoping67@aliyun.com

Transjugular vein bypass for the treatment of hemodialysis arteriovenous fistula dysfunction caused by subclavian vein occlusion

HE Lanlan1, YANG Ke2, REN Wanjun3, WANG Xiaoping3   

  1. 1. School of Clinical Medicine, Shandong Second Medical University, Weifang 261053, Shandong, China;
    2. Department of Nephrology, Pingyu County Peoples Hospital, Pingyu 463400, Henan, China;
    3. Department of Nephrology, Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, Shandong, China
  • Published:2024-07-15

摘要: 目的 探讨经颈部静脉旁路术治疗血液透析血管通路相关锁骨下静脉闭塞的临床效果。 方法 回顾性分析3例锁骨下静脉闭塞所致透析内瘘失功患者的临床特点、经颈部静脉旁路术的要点及术后内瘘功能状况。 结果 3例患者经颈部静脉旁路术均取得成功,术后均未出现相关并发症。病例1术后随访9个月,转位血管通畅,内瘘功能良好;病例2术后随访33个月,两次因吻合口狭窄行PTA治疗,现人工血管通畅,内瘘功能良好;病例3术后随访15个月,人工血管通畅,内瘘功能良好。 结论 锁骨下静脉闭塞经腔内治疗等措施无法成功或风险较大时,颈部静脉旁路术可以作为一种选择。

关键词: 血液透析, 动静脉内瘘, 中心静脉狭窄, 锁骨下静脉闭塞, 解剖外旁路术

Abstract: Objective To investigate the clinical effect of transjugular vein bypass for the treatment of hemodialysis arteriovenous fistula dysfunction caused by subclavian vein occlusion. Methods Clinical characteristics, key points of transjugular venous bypass, and postoperative fistula function of three cases with hemodialysis arteriovenous fistula dysfunction caused by subclavian vein occlusion were retrospectively analyzed. Results Transjugular venous bypass was successful in all three patients, and none of them had any related postoperative complications. Patient 1 was followed up for 9 months postoperatively, with a patent transposition vessel and good arteriovenous fistula function. Patient 2 was followed for 33 months postoperatively, with PTA twice for anastomotic stenosis; the artificial blood vessel was patency and the arteriovenous fistula function was good. Patient 3 was followed up for 15 months postoperatively, with a patent artificial blood vessel and good arteriovenous fistula function. Conclusion Transjugular venous bypass can be an option when endovascular treatment for subclavian vein occlusion is unsuccessful or risky.

Key words: Hemodialysis, Arteriovenous fistula, Central vein stenosis, Subclavian vein occlusion, Extra-anatomic bypass

中图分类号: 

  • R459.5
[1] Zubair MM, Bennett ME, Peden EK. Left axillary to right atrium anterior chest wall graft using bovine carotid artery conduit[J]. J Vasc Access, 2018, 19(2): 187-190.
[2] Edwards JB, Brooks JD, Wooster MD, et al. Outcomes of venous bypass combined with thoracic outlet decompression for treatment of upper extremity central venous occlusion[J]. J Vasc Surg Venous Lymphat Disord, 2019, 7(5): 660-664.
[3] Suliman A, Greenberg JI, Angle N. Surgical bypass of symptomatic central venous obstruction for arteriovenous fistula salvage in hemodialysis patients[J]. Ann Vasc Surg, 2008, 22(2): 203-209.
[4] Saravana KS, Zainal AA. Extra-anatomical veno-venous surgical bypass for central vein occlusion in patients with ipsilateral arterio-venous fistula(AVF)for haemodialysis-a single centre experience[J]. Med J Malaysia, 2017, 72(1): 3-6.
[5] Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update[J]. Am J Kidney Dis, 2020, 75(4 Suppl 2): S1-S164.
[6] 金其庄,王玉柱,叶朝阳,等.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化, 2019, 18(6): 365-380.
[7] 血液透析通路相关中心静脉病变介入治疗专家组.血液透析通路相关中心静脉病变介入治疗专家建议书[J].临床肾脏病, 2023, 23(4): 265-283. Expert Group of Interventional Therapy for Central Venous Disease Related with Hemodialysis Access. Expert recommendation on interventional therapy for central venous disease related with hemodialysis access [J]. Journal of Clinical Nephrology, 2023, 23(4): 265-283.
[8] Krishna VN, Eason JB, Allon M. Central venous occlusion in the hemodialysis patient[J]. Am J Kidney Dis, 2016, 68(5): 803-807.
[9] Saleh M, Ali H, Elbadawy A, et al. Balloon angioplasty with selective stenting strategy in treatment of hemodialysis related central vein occlusive lesions[J]. Int Angiol, 2017, 36(5): 462-466.
[10] Agarwal AK. Central vein wtenosis[J]. Am J Kidney Dis, 2013, 61(6): 1001-1015.
[11] 阮毅,于洋,熊于勤,等.血液透析相关中心静脉闭塞性疾病诊治进展[J].生物医学工程研究, 2022, 41(3): 332-339. RUAN Yi, YU Yang, XIONG Yuqin, et al. Diagnosis and treatment of central venous occlusive diseases in patients on maintenance hemodialysis [J]. Journal of Biomedical Engineering Research, 2022, 41(3): 332-339.
[12] Cakir S, Guzelbey T, Mutlu IN, et al. Comparison of functional patency rates between paclitaxel-eluting versus plain balloon angioplasty in hemodialysis patients with central venous stenosis: an intra-individual comparison study[J]. Ther Apher Dial, 2022, 26(1): 185-190.
[13] Kitrou P, Katsanos K, Karnabatidis D. Management of central venous stenoses and occlusions[J]. Cardiovasc Intervent Radiol, 2023, 46(9): 1182-1191.
[14] 刘应婷,张静,张胜男,等.血液透析患者中心静脉狭窄的诊疗进展[J].中国血液净化, 2022, 21(9): 672-675. LIU Yingting, ZHANG Jing, ZHANG Shengnan, et al. Recent progress in the diagnosis and treatment of central vein stenosis in hemodialysis patients [J]. Chinese Journal of Blood Purification, 2022, 21(9): 672-675.
[15] Liu Z, Huang J, Tang Y, et al. Outcomes of stent grafts for treatment of central venous disease in hemodialysis patients[J]. J Vasc Access, 2022: 11297298221134142. doi: 10.1177/11297298221134142.
[16] Chen B, Lin R, Dai H, et al. Sharp recanalization for treatment of central venous occlusive disease in hemodialysis patients[J]. J Vasc Surg Venous Lymphat Disord, 2022, 10(2): 306-312.
[17] Meric M, Oztas DM, Cakir MS, et al. A surgical method to be reminded for the treatment of symptomatic ipsilateral central venous occlusions in patients with hemodialysis access: axillo-axillary venous bypass case report and review of the literature[J]. Vascular, 2023, 31(5): 1017-1025.
[18] Modabber M, Kundu S. Central venous disease in hemodialysis patients: an update[J]. Cardiovasc Intervent Radiol, 2013, 36(4): 898-903.
[19] Rehman ZU. Extra-anatomical cephalic to internal jugular vein bypass for central venous occlusion[J]. J Coll Physicians Surg Pak, 2020, 30(2): 219-221.
[20] Kavallieratos N, Kokkinos A, Kalocheretis P. Axillary to saphenous vein bypass for treatment of central venous obstruction in patients receiving dialysis[J]. J Vasc Surg, 2004, 40(4): 640-643.
[21] Wisselink W, Money SR, Becker MO, et al. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction[J]. Am J Surg, 1993, 166(2): 200-204.
[22] Dammers R, de Haan MW, Planken NR, et al. Central vein obstruction in hemodialysis patients: results of radiological and surgical intervention[J]. Eur J Vasc Endovasc Surg, 2003, 26(3): 317-321.
[23] Sasaki N, Hiramatsu T, Hasegawa Y, et al. Cerebral hemorrhage due to intracranial venous reflux associated with left brachiocephalic vein occlusion in a hemodialysis patient[J]. Surg Neurol Int, 2023, 14: 79. doi: 10.25259/SNI_108_2023.
[24] Kang H, Park ST. Resolved cerebral venous hypertension after angioplasty of central venous stenosis in a hemodialysis patient: a case report[J]. Taehan Yongsang Uihakhoe Chi, 2022, 83(1): 206-211.
[25] 冯静静,张鲁伟,赵鹏,等.彩色多普勒超声在终末期肾病患者自体动静脉内瘘术前评估及术后监测中的应用[J].山东大学学报(医学版), 2018, 56(7): 65-69. FENG Jingjing, ZHANG Luwei, ZHAO Peng, et al. Application of CDFI in the stablishment and evaluation of autogenous arteriovenousfistula[J]. Journal of Shandong University(Health Sciences), 2018, 56(7): 65-69.
[1] 李建,孙云. 新入维持性血液透析患者2年内死亡的危险因素[J]. 山东大学学报 (医学版), 2024, 62(4): 48-53.
[2] 王园园,孙云. 合并新型冠状病毒肺炎的维持性血液透析患者死亡危险因素[J]. 山东大学学报 (医学版), 2023, 61(11): 68-73.
[3] 冯静静,张鲁伟,赵鹏,郭宁,田军,崔先泉. 彩色多普勒超声在终末期肾病患者自体动静脉内瘘术前评估及术后监测中的应用[J]. 山东大学学报 (医学版), 2018, 56(7): 65-69.
[4] 牛纪媛,王方利,张瑞斌,高庆贞,贠萍,王琪,张珊,白雪,王小平. 局部外膜缓释西罗莫司对内瘘血管内膜增生的影响[J]. 山东大学学报(医学版), 2016, 54(8): 17-21.
[5] 王静, 李娟. 无肝素血液透析的疗效及护理体会[J]. 山东大学学报(医学版), 2014, 52(Z1): 185-186.
[6] 蔡宇, 张颖, 徐成. 维持性血液透析患者肾性骨病预防和护理[J]. 山东大学学报(医学版), 2014, 52(Z1): 154-155.
[7] 石正兰. 预见性护理干预减少血液透析患者急性左心衰竭发作的应用[J]. 山东大学学报(医学版), 2014, 52(Z1): 182-182.
[8] 谭芳, 章厚芬. 不同途径深静脉置管在慢性肾衰竭患者 血液透析中的应用[J]. 山东大学学报(医学版), 2014, 52(S2): 134-135.
[9] 梁波. 连续性静脉-静脉血液滤过治疗 严重乳酸性酸中毒临床观察[J]. 山东大学学报(医学版), 2014, 52(S2): 31-31.
[10] 杨红兰. 慢性肾功能衰竭血液透析患者合并恶性肿瘤22例临床分析[J]. 山东大学学报(医学版), 2014, 52(S1): 127-128.
[11] 李凤波, 高晓芳, 王小双. 基层医院维持性血液透析患者生存质量相关影响因素调查分析[J]. 山东大学学报(医学版), 2014, 52(S1): 46-46.
[12] 姜祥品, 崔美玉, 孔祥雷, 许冬梅. 透析患者应用果糖二磷酸钠出现代谢性脑病1例[J]. 山东大学学报(医学版), 2014, 52(8): 111-112.
[13] 孔祥雷,宝群,魏勇,贾晓妍,陈萍,唐利军,王尊松,李文斌,崔美玉,许冬梅. 血液透析患者矿物质和骨代谢紊乱控制情况的单中心研究[J]. 山东大学学报(医学版), 2012, 50(8): 116-119.
[14] 王会1,王菊生2,时一民1,姚子明3,孙云1,肖合存1,赵晓田4,赵长峰4. 维持性血液透析患者营养状况分析[J]. 山东大学学报(医学版), 2011, 49(9): 59-.
[15] 隋准,王梅. 在线尿素清除率监测估算终末期肾病患者血液透析尿素清除指数的研究[J]. 山东大学学报(医学版), 2010, 48(12): 94-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!